30 Jul 2021 12:21
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | UDG HEALTHCARE PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 29 July 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
6,833,525 | 2.71% | 196,390 | 0.08% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
141,935 | 0.06% | 6,557,622 | 2.60% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
(4) | TOTAL: |
|
|
|
|
6,975,460 | 2.77% | 6,754,012 | 2.68% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 398 | 10.7800 GBP |
| Purchase | 11,971 | 10.7818 GBP |
| Purchase | 14,905 | 10.7700 GBP |
| Purchase | 25,193 | 10.7799 GBP |
| Purchase | 31,982 | 10.7784 GBP |
| Purchase | 42,354 | 10.7756 GBP |
| Purchase | 55,235 | 10.7771 GBP |
| Sale | 929 | 10.7782 GBP |
| Sale | 3,102 | 10.7700 GBP |
| Sale | 9,206 | 10.7800 GBP |
| Sale | 11,796 | 10.7796 GBP |
| Sale | 13,666 | 10.7705 GBP |
| Sale | 62,427 | 10.7740 GBP |
(b) Derivatives transactions (other than options transactions)
| Product Name | Nature of transaction | Number of relevant securities | Price per |
| unit | ||
| CFD | Long | 929 | 10.7782 GBP |
| CFD | Long | 1,970 | 10.7700 GBP |
| SWAP | Long | 4,396 | 10.7789 GBP |
| SWAP | Long | 16,086 | 10.7800 GBP |
| CFD | Long | 17,570 | 10.7711 GBP |
| SWAP | Long | 17,665 | 10.7793 GBP |
| SWAP | Long | 28,844 | 10.7706 GBP |
| SWAP | Short | 1,208 | 10.7836 GBP |
| SWAP | Short | 1,594 | 10.7771 GBP |
| SWAP | Short | 4,523 | 10.7700 GBP |
| SWAP | Short | 10,531 | 10.7873 GBP |
| CFD | Short | 150,473 | 10.7781 GBP |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 30 Jul 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20210730005281/en/
Copyright Business Wire 2021